RAFAL KREJZA: Open Payments
NPI 1619236213 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 61 payments from 17 companies in 2025. Trend: 2023 $2,055 · 2024 $945 · 2025 $1,532
Food & beverage: $1,532
| Company | Payments | Amount |
|---|---|---|
| PROTEGA PHARMACEUTIALS INC | 5 | $249 |
| Abbott Laboratories | 5 | $228 |
| ABBVIE INC. | 11 | $182 |
| Globus Medical, Inc. | 2 | $175 |
| Forte Bio-Pharma LLC | 19 | $142 |
| Medtronic, Inc. | 2 | $136 |
| SPR Therapeutics, Inc | 1 | $103 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Boston Scientific Corporation | 2 | $46 |
Products named: ROXYBOND, ETERNA, Senza, PROLATE, INCEPTIV, SPRINT PNS System, QULIPTA, RELISTOR.
Industry payments across NE — which companies pay providers there.
